This report provides a comprehensive analysis of the global Polyurethane Intravenous (IV) Catheter market, projecting significant growth through 2032. It examines essential clinical applications, including infusions and blood transfusions, while segmenting the market by type, such as single and multi-lumen catheters, and end-user sectors like hospitals and clinics. Detailed regional insights cover major markets in the Americas, APAC, and Europe. Furthermore, the study evaluates competitive dynamics among key industry players, highlighting strategic trends, market shares, and emerging opportunities.

Market Overview

The global Polyurethane Intravenous (IV) Catheter market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate. Intravenous catheters serve as essential medical devices primarily utilized for clinical operations, including infusion, blood transfusion, drug injection, and venous blood collection.

Regional Market Analysis

Global Outlook

The report provides a comprehensive analysis of the world Polyurethane Intravenous (IV) Catheter industry, including a review of total global sales in 2025 and detailed projections for the period from 2026 through 2032. The analysis is broken down by region, market sector, and sub-sector, providing detailed insights in US$ millions.

Regional Growth Projections

• United States: The market is estimated to increase from 2025 through 2032, following a consistent compound annual growth rate.
• China: The market is estimated to increase from 2025 through 2032, following a consistent compound annual growth rate.
• Europe: The market is estimated to increase from 2025 through 2032, following a consistent compound annual growth rate.

Market Segmentation

By Type

• Single Lumen
• Multi-Lumens

By Application

• Hospital
• Clinic
• Other

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• Terumo
• Argon Medical
• B. Braun Medical
• Vygon
• ICU Medical
• AMECATH
• Welllead

Market Dynamics & Strategy

In 2025, the two largest global companies occupied a significant portion of the market revenue. This report highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments and M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Polyurethane Intravenous (IV) Catheter portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market.

Research Methodology & Insights

This Insight Report evaluates key market trends, drivers, and affecting factors shaping the global outlook. Using a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, the study offers a nuanced view of the current state and future trajectory of the industry. The report identifies emerging pockets of opportunity by breaking down forecasts by type, application, geography, and market size.

Key Questions Addressed

• What is the 10-year outlook for the global Polyurethane Intravenous (IV) Catheter market?
• What factors are driving Polyurethane Intravenous (IV) Catheter market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Polyurethane Intravenous (IV) Catheter market opportunities vary by end market size?
• How does Polyurethane Intravenous (IV) Catheter break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Polyurethane Intravenous (IV) Catheter Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Polyurethane Intravenous (IV) Catheter by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Polyurethane Intravenous (IV) Catheter by Country/Region, 2021, 2025 & 2032

  • 2.2 Polyurethane Intravenous (IV) Catheter Segment by Type

    • 2.2.1 Single Lumen

    • 2.2.2 Multi-Lumens

    • 2.2.3 Polyurethane Intravenous (IV) Catheter Sales by Type

      • 2.2.3.1 Global Polyurethane Intravenous (IV) Catheter Sales Market Share by Type (2021-2026)
      • 2.2.3.2 Global Polyurethane Intravenous (IV) Catheter Revenue and Market Share by Type (2021-2026)
      • 2.2.3.3 Global Polyurethane Intravenous (IV) Catheter Sale Price by Type (2021-2026)

  • 2.3 Polyurethane Intravenous (IV) Catheter Segment by Application

    • 2.3.1 Hospital

    • 2.3.2 Clinic

    • 2.3.3 Other

    • 2.3.4 Polyurethane Intravenous (IV) Catheter Sales by Application

      • 2.3.4.1 Global Polyurethane Intravenous (IV) Catheter Sale Market Share by Application (2021-2026)
      • 2.3.4.2 Global Polyurethane Intravenous (IV) Catheter Revenue and Market Share by Application (2021-2026)
      • 2.3.4.3 Global Polyurethane Intravenous (IV) Catheter Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Polyurethane Intravenous (IV) Catheter Breakdown Data by Company

    • 3.1.1 Global Polyurethane Intravenous (IV) Catheter Annual Sales by Company (2021-2026)

    • 3.1.2 Global Polyurethane Intravenous (IV) Catheter Sales Market Share by Company (2021-2026)

  • 3.2 Global Polyurethane Intravenous (IV) Catheter Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Polyurethane Intravenous (IV) Catheter Revenue by Company (2021-2026)

    • 3.2.2 Global Polyurethane Intravenous (IV) Catheter Revenue Market Share by Company (2021-2026)

  • 3.3 Global Polyurethane Intravenous (IV) Catheter Sale Price by Company

  • 3.4 Key Manufacturers Polyurethane Intravenous (IV) Catheter Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Polyurethane Intravenous (IV) Catheter Product Location Distribution

    • 3.4.2 Players Polyurethane Intravenous (IV) Catheter Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Polyurethane Intravenous (IV) Catheter by Geographic Region

  • 4.1 World Historic Polyurethane Intravenous (IV) Catheter Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Polyurethane Intravenous (IV) Catheter Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Polyurethane Intravenous (IV) Catheter Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Polyurethane Intravenous (IV) Catheter Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Polyurethane Intravenous (IV) Catheter Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Polyurethane Intravenous (IV) Catheter Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Polyurethane Intravenous (IV) Catheter Sales Growth

  • 4.4 APAC Polyurethane Intravenous (IV) Catheter Sales Growth

  • 4.5 Europe Polyurethane Intravenous (IV) Catheter Sales Growth

  • 4.6 Middle East & Africa Polyurethane Intravenous (IV) Catheter Sales Growth

• 5 Americas

  • 5.1 Americas Polyurethane Intravenous (IV) Catheter Sales by Country

    • 5.1.1 Americas Polyurethane Intravenous (IV) Catheter Sales by Country (2021-2026)

    • 5.1.2 Americas Polyurethane Intravenous (IV) Catheter Revenue by Country (2021-2026)

  • 5.2 Americas Polyurethane Intravenous (IV) Catheter Sales by Type (2021-2026)

  • 5.3 Americas Polyurethane Intravenous (IV) Catheter Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Polyurethane Intravenous (IV) Catheter Sales by Region

    • 6.1.1 APAC Polyurethane Intravenous (IV) Catheter Sales by Region (2021-2026)

    • 6.1.2 APAC Polyurethane Intravenous (IV) Catheter Revenue by Region (2021-2026)

  • 6.2 APAC Polyurethane Intravenous (IV) Catheter Sales by Type (2021-2026)

  • 6.3 APAC Polyurethane Intravenous (IV) Catheter Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Polyurethane Intravenous (IV) Catheter by Country

    • 7.1.1 Europe Polyurethane Intravenous (IV) Catheter Sales by Country (2021-2026)

    • 7.1.2 Europe Polyurethane Intravenous (IV) Catheter Revenue by Country (2021-2026)

  • 7.2 Europe Polyurethane Intravenous (IV) Catheter Sales by Type (2021-2026)

  • 7.3 Europe Polyurethane Intravenous (IV) Catheter Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Polyurethane Intravenous (IV) Catheter by Country

    • 8.1.1 Middle East & Africa Polyurethane Intravenous (IV) Catheter Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Polyurethane Intravenous (IV) Catheter Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Polyurethane Intravenous (IV) Catheter Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Polyurethane Intravenous (IV) Catheter Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Polyurethane Intravenous (IV) Catheter

  • 10.3 Manufacturing Process Analysis of Polyurethane Intravenous (IV) Catheter

  • 10.4 Industry Chain Structure of Polyurethane Intravenous (IV) Catheter

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Polyurethane Intravenous (IV) Catheter Distributors

  • 11.3 Polyurethane Intravenous (IV) Catheter Customer

• 12 World Forecast Review for Polyurethane Intravenous (IV) Catheter by Geographic Region

  • 12.1 Global Polyurethane Intravenous (IV) Catheter Market Size Forecast by Region

    • 12.1.1 Global Polyurethane Intravenous (IV) Catheter Forecast by Region (2027-2032)

    • 12.1.2 Global Polyurethane Intravenous (IV) Catheter Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Polyurethane Intravenous (IV) Catheter Forecast by Type (2027-2032)

  • 12.7 Global Polyurethane Intravenous (IV) Catheter Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Terumo

    • 13.1.1 Terumo Company Information

    • 13.1.2 Terumo Polyurethane Intravenous (IV) Catheter Product Portfolios and Specifications

    • 13.1.3 Terumo Polyurethane Intravenous (IV) Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Terumo Main Business Overview

    • 13.1.5 Terumo Latest Developments

  • 13.2 Argon Medical

    • 13.2.1 Argon Medical Company Information

    • 13.2.2 Argon Medical Polyurethane Intravenous (IV) Catheter Product Portfolios and Specifications

    • 13.2.3 Argon Medical Polyurethane Intravenous (IV) Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Argon Medical Main Business Overview

    • 13.2.5 Argon Medical Latest Developments

  • 13.3 B. Braun Medical

    • 13.3.1 B. Braun Medical Company Information

    • 13.3.2 B. Braun Medical Polyurethane Intravenous (IV) Catheter Product Portfolios and Specifications

    • 13.3.3 B. Braun Medical Polyurethane Intravenous (IV) Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 B. Braun Medical Main Business Overview

    • 13.3.5 B. Braun Medical Latest Developments

  • 13.4 Vygon

    • 13.4.1 Vygon Company Information

    • 13.4.2 Vygon Polyurethane Intravenous (IV) Catheter Product Portfolios and Specifications

    • 13.4.3 Vygon Polyurethane Intravenous (IV) Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Vygon Main Business Overview

    • 13.4.5 Vygon Latest Developments

  • 13.5 ICU Medical

    • 13.5.1 ICU Medical Company Information

    • 13.5.2 ICU Medical Polyurethane Intravenous (IV) Catheter Product Portfolios and Specifications

    • 13.5.3 ICU Medical Polyurethane Intravenous (IV) Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 ICU Medical Main Business Overview

    • 13.5.5 ICU Medical Latest Developments

  • 13.6 AMECATH

    • 13.6.1 AMECATH Company Information

    • 13.6.2 AMECATH Polyurethane Intravenous (IV) Catheter Product Portfolios and Specifications

    • 13.6.3 AMECATH Polyurethane Intravenous (IV) Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 AMECATH Main Business Overview

    • 13.6.5 AMECATH Latest Developments

  • 13.7 Welllead

    • 13.7.1 Welllead Company Information

    • 13.7.2 Welllead Polyurethane Intravenous (IV) Catheter Product Portfolios and Specifications

    • 13.7.3 Welllead Polyurethane Intravenous (IV) Catheter Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Welllead Main Business Overview

    • 13.7.5 Welllead Latest Developments

• 14 Research Findings and Conclusion